CUSTOPHARM

CUSTOPHARM has steadily developed, creating more than 30 products that serve over 100 institutions in the pharmaceutical industry. In 2015, we partnered with Water Street Healthcare Partners, a strategic investor with extensive pharmaceutical expertise, to accelerate CUSTOPHARM’s growth. Since then, we have been committed to becoming a leader in U.S. generic injectable medications while striving to make treatments more accessible through our high-barrier product development portfolio.